Offer - Urjas Oil for just ₹ 1
Atarap 4 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Tourette Syndrome. Other than this, Atarap 4 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Atarap 4 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Atarap 4 Tablet include Constipation, Blurred vision. Apart from the aforementioned side effects, Atarap 4 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Atarap 4 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Atarap 4 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. It is important to know if Atarap 4 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Atarap 4 Tablet related warnings section.
Individuals suffering from medical conditions like Tardive Dyskinesia, Dementia must refrain from the use of Atarap 4 Tablet since this can cause severe adverse effects. Other contraindications of Atarap 4 Tablet have been discussed in the sections ahead.
Drug interactions for Atarap 4 Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Atarap 4 Tablet is not safe while driving, and is not addiction.
Atarap 4 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Atarap 4 Tablet safe for pregnant women?
Atarap may have some side effects during pregnancy. Pregnant women should discontinue the use of Atarap, and talk to their doctor, if they notice any discomfort.
Is the use of Atarap 4 Tablet safe during breastfeeding?
Atarap should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Atarap 4 Tablet on the Kidneys?
Atarap has very mild side effects on the kidneys.
What is the effect of Atarap 4 Tablet on the Liver?
Side effects of Atarap rarely affect the liver.
What is the effect of Atarap 4 Tablet on the Heart?
Atarap has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Atarap 4 Tablet unless your doctor advises you to do so -
Is this Atarap 4 Tablet habit forming or addictive?
Atarap 4 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Atarap 4 Tablet, you should not drive or work on any heavy machine, as Atarap 4 Tablet can make you drowsy.
Is it safe?
Yes, Atarap 4 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Atarap 4 Tablet can treat mental disorders.
Interaction between Food and Atarap 4 Tablet
When consumed with certain foods, Atarap 4 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Atarap 4 Tablet
Consult your doctor before consuming alcohol while taking Atarap 4 Tablet as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orap® (Pimozide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 440,441
